26.02.2013 Views

CHAN Kwan Yi Queeny - The Chinese University of Hong Kong

CHAN Kwan Yi Queeny - The Chinese University of Hong Kong

CHAN Kwan Yi Queeny - The Chinese University of Hong Kong

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Department <strong>of</strong> Clinical Oncology<br />

WONG Sze Chuen Cesar; <strong>CHAN</strong> J K; CHEUK W; <strong>CHAN</strong> Ming Lok; HUI Edwin P; LAM Yan<br />

Yee; <strong>CHAN</strong> Sai Kit Andrew; AU Chi Chuen; CHOI Ching Gee and <strong>CHAN</strong> Anthony Tak<br />

Cheung. "Her-2 gene amplification is a common event in natural killer T-cell lymphoma. Abstract :<br />

5540". Paper presented in the American Association for Cancer Research Annual Scientific<br />

Meeting, one pgs. usa, 2009.04.<br />

YING JIANMING; POON Fan Fong; YU Jun; GENG Hua; WONG Ho Yan; QIU G H; GOH<br />

H K; RHA S Y; TIAN Linwei; <strong>CHAN</strong> Anthony Tak Cheung; SUNG Joseph Jao <strong>Yi</strong>u and TAO<br />

Qian. "DLEC1 is a Functional 3p22.3 Tumour Suppressor Silenced by Promoter CpG Methylation in<br />

Colon and Gastric Cancers". British Journal <strong>of</strong> Cancer vol.100 no.4, pp.663-9. Nature Publishing<br />

Group on behalf <strong>of</strong> Cancer Research UK, 2009.02.24.<br />

OHE Y; ICHINOSE Y; NISHIWAKI Y; YAMAMOTO N; NEGORO S; DUFFIELD E; JIANG<br />

H; SAIJO N; MOK Shu Kam Tony and FUKUOKA M. "Phase III, Randomized, Open-Label,<br />

First-Line Study <strong>of</strong> Gefitinib (G) Versus Carboplatin/Paclitaxel (C/P) in Selected Patients (pts) with<br />

Advanced Non-Small Cell Lung Cancer (NSCLC) (IPASS): Evaluation <strong>of</strong> Recuits in Japan". Paper<br />

presented in the <strong>The</strong> American Society <strong>of</strong> Clinical Oncology 2009 Annual Meeting, organized by<br />

ASCO, 1 pgs. United States <strong>of</strong> America, 2009.05.<br />

<strong>CHAN</strong> Lam Stephen; MO Kwok Fai; JOHNSON Philip James; HUI Pun; MA Buig Yue<br />

Brigette; HO Wing Ming; LAM Kwok Chi; <strong>CHAN</strong> Anthony Tak Cheung; MOK Shu Kam Tony<br />

and YEO Winnie. "New utility <strong>of</strong> an old marker: serial alpha-fetoprotein measurement in predicting<br />

radiologic response and survival <strong>of</strong> patients with hepatocellular carcinoma undergoing systemic<br />

chemotherapy". Journal <strong>of</strong> Clinical Oncology vol.27 no.3, pp.446-52. United States <strong>of</strong> America:<br />

American Society <strong>of</strong> Clinical Oncology, 2009.01.20.<br />

LUI Wai Yan Vivian; LAU Pik Yuk Cecilia; NG Margaret; CHENG S H; TSANG Chi Man;<br />

TSAO Sai Wah; LEI Ieng-Kit Kenny and <strong>CHAN</strong> Anthony Tak Cheung. "Antitumor activity <strong>of</strong><br />

TAS-106 (3'-ethynylcytidine), a novel potent inhibitor <strong>of</strong> RNA polymerase, in Nasopharyngeal cancer<br />

(NPC) cells. Abstract 873". Paper presented in the AACR Annual Meeting, Denver, Colorado, USA,<br />

2009 April 18-22, one pgs. Colorado, United States <strong>of</strong> America, 2009.04.18.<br />

莫樹錦. . 《微創手術診斷與治療》 Anthony P.C. <strong>Yi</strong>m 編. 頁 46-51. 中國 <strong>Hong</strong><br />

<strong>Kong</strong>: <strong>The</strong> <strong>Chinese</strong> <strong>University</strong> Press, 2009.<br />

WONG Sze Chuen Cesar; <strong>CHAN</strong> Charles M L; MA Buig Yue Brigette; LAM Yan Yee; CHOI<br />

Ching Gee; AU Chi Chuen; <strong>CHAN</strong> Sai Kit and <strong>CHAN</strong> Anthony Tak Cheung. "Advanced<br />

proteomic technologies for cancer biomarker discovery". Expert Review <strong>of</strong> Proteomics<br />

vol.6 no.2, pp.123-34. United Kingdom: Future Drugs Ltd.,, 2009.04.<br />

Faculty <strong>of</strong> Medicine

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!